Current Edition

active pharmaceutical ingredients

Understanding the Challenges of Highly Potent Actives

A rising number of active pharmaceutical ingredients (APIs) are classed as “highly potent”. They are being increasingly harnessed by pharma companies developing oral solid dose …

Continue Reading →
APIs

Formulation and Process Considerations for Optimising Spray-Dried Solid Dispersions

Spray drying active pharmaceutical ingredients (APIs) in solution to overcome solubility hurdles requires part craft and great attention to process variables. Today’s APIs are increasingly …

Continue Reading →
agreement

Noramco and SPI Pharma sign agreement to develop ready-to-implement, patient-friendly formulations for pharmaceutical manufacturers

Noramco, a global leader in the manufacture and supply of controlled substance active pharmaceutical ingredients (APIs), and SPI Pharma, a global leader in the manufacture …

Continue Reading →
APIs

Pharma set for prosperous 2018 as 44,500 attend CPhI Worldwide

CPhI Worldwide, organised by UBM, closes its 28th edition with pre-audit figures indicating a record-breaking attendance of over 44,500* and 2,598 exhibitors. Held in Frankfurt …

Continue Reading →